Muestra la distribución de la producción WoS, Scopus y SciELO del autor.
Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.
| Firmas del autor | |
| Nombre | SERRANO, EILEEN |
| Género | Mujer |
| Área Principal WOS | Medicine, Research & Experimental; Pediatrics; Cell Biology; |
| Afiliación Principal | Pontificia Universidad Católica De Chile |
Publicaciones en Chile
Citas Totales
Afiliaciones Chilenas
| WOS | #Pub |
|---|---|
| Medicine, Research & Experimental | 2 |
| Pediatrics | 1 |
| Cell Biology | 1 |
| Multidisciplinary Sciences | 1 |
| Gastroenterology & Hepatology | 1 |
| Scopus | #Pub |
|---|
| SciELO | #Pub |
|---|
| Título | Año | Citas | Tipo | Revista | Indexada |
|---|---|---|---|---|---|
| Omicron Variant Spike Specific Antibody Binding And Fc Activity Are Preserved In Recipients Of M Rna Or Inactivated Covid 19 Vaccines | 2022 | 47 | artículo de investigación | Science Translational Medicine | WoS Scopus |
| High Prevalence Of Sars Co V 2 Detection And Prolonged Viral Shedding In Stools: A Systematic Review And Cohort Study | 2022 | 4 | revisión | Gastroenterologia Y Hepatologia | WoS Scopus |
| Induction Of Sars Co V 2 Neutralizing Antibodies By Corona Vac And Bnt162b2 Vaccines In Naive And Previously Infected Individuals | 2022 | 18 | artículo de investigación | E Bio Medicine | WoS Scopus |
| Short Term Complications And Post Acute Sequelae In Hospitalized Paediatric Patients With Covid 19 And Obesity: A Multicenter Cohort Study | 2023 | 1 | artículo de investigación | Pediatric Obesity | WoS Scopus |
| Waning And Boosting Of Antibody Fc Effector Functions Upon Sars Co V 2 Vaccination | 2023 | 0 | artículo de investigación | Nature Communications | WoS Scopus |
| Palabra Clave | #Pub |
|---|---|
| covid-19 | 3 |
| neutralizing antibody persistence | 1 |
| vaccination boost | 1 |
| states | 1 |
| serological response | 1 |
| sars-cov-2 vaccines | 1 |
| sars-cov-2 | 1 |
| sars coronavirus | 1 |
| rna | 1 |
| risk | 1 |
| receptor-binding domain | 1 |
| post-acute covid-19 syndrome | 1 |
| obesity | 1 |
| novel coronavirus | 1 |
| 2019-ncov-2 | 1 |
| neutralizing antibodies | 1 |
| monoclonal-antibody | 1 |
| intensive care units | 1 |
| effector functions | 1 |
| durability | 1 |
| diarrhea | 1 |
| coronavirus | 1 |
| clinical characteristics | 1 |
| child | 1 |
| adolescent | 1 |